SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-23-029354
Filing Date
2023-06-22
Accepted
2023-06-22 14:22:58
Documents
15
Period of Report
2023-06-22
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K srpt-20230622.htm   iXBRL 8-K 61637
2 EX-99.1 srpt-ex99_1.htm EX-99.1 65700
3 GRAPHIC img45281506_0.jpg GRAPHIC 5999
4 GRAPHIC img45281506_1.jpg GRAPHIC 107673
  Complete submission text file 0000950170-23-029354.txt   409056

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT srpt-20230622.xsd EX-101.SCH 2466
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT srpt-20230622_pre.xml EX-101.PRE 9451
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT srpt-20230622_lab.xml EX-101.LAB 12806
9 EXTRACTED XBRL INSTANCE DOCUMENT srpt-20230622_htm.xml XML 4527
Mailing Address 215 FIRST STREET SUITE 415 CAMBRIDGE MA 02142
Business Address 215 FIRST STREET SUITE 415 CAMBRIDGE MA 02142 617-274-4000
Sarepta Therapeutics, Inc. (Filer) CIK: 0000873303 (see all company filings)

IRS No.: 930797222 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-14895 | Film No.: 231032927
SIC: 2834 Pharmaceutical Preparations